A product specifically designed to treat aging eye disorders such
as cataracts, Conjunctisan A contains natural lysates, which purport
to improve eye conditions by stimulating the natural healing and
repair processes. Regular, longer use of conjunctisan A may improve
eyesight in cataract sufferers, as well as myopia.
Conjunctisan A's anti-aging potential benefits include treatment
and prevention of cataracts, improvement of eye irritation due to
environmental factors, and general improvement of aging eye deterioration
due to macular degeneration, opacity of the lens, retina changes
and degenerative eye complaints.
Pharmacology: This product contains a plethora of bovine origin
macromolecular organ factors from corresponding eye sections. Each
liquid capsule contains; 0.2ng bulb.oc. fet., 0.05ng lenx, 0.1ng
fet. Vessels, 0.15ng placenta fet., 0.05pg retina, 0.05pg optic
nerve, 0.1pg choroid, 0.1pg hyaloid body, 0.05pg cerebral cortex,
0.05pg diencephalon, as well as the pharmaceutical substances 0.074ug
deslanoside C, 5ug aesulin and 5ug sodium dodecyl sulfate, 4 percent
glycerol ad 0.5ml saline (0.7 percent).
Side Effects and Contraindications: No known side effects or contraindications
reported by manufacturer.
Distribution: VitOrgan of Germany distributes Conjunctisan A in
0.5 ml liquid droppers.
Notes: Considered to be homeopathic. When used continuously for
4 to 6 weeks, some users may benefit from improved vision; after
that period it is important to continue a maintenance program in
order for the condition not to regress.
to Anti-Aging Medicine Index